10x Genomics, Inc. (NASDAQ:TXG) introduces Chromium Flex assay, increasing single-cell experiment capacity. The system supports 384 samples in a 96-well plate format, processing up to 100 million cells weekly. The upgrade targets high cell-number and sample-number applications, offering labs bulk method throughput with single-cell resolution. The assay is now available globally for academic, biotech, and pharma labs seeking high-throughput solutions.

Read more at Yahoo Finance: 10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch